ROMVIMZA

vimseltinib · Deciphera Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ROMVIMZA, covering 2025-02-14 to 2026-02-11. Get the full timeline:

Most recent: EMA Authorised: Romvimza (vimseltinib dihydrate) — Deciphera Pharmaceuticals (Netherlands) B.V.